Is Jeff Siegel’s “Molecule 520” Stock Legit?

Welcome to my review of Jeff Siegel’s presentation regarding something he refers to as Molecule 520.

Jeff claims to have discovered a miracle molecule can cure many illnesses while at the same time creating an investment opportunity for investors who know where to wager their bets.

In this review, I will walk you through what that means and unveil the company that he thinks presents you with the best opportunity should you decide to take this seriously.

Before I start…

If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.

It’s helped me earn over $300,000 in the last 12 months alone:

Go here to see my no.1 recommendation for making money online

(This is a 100% free training)

Is Jeff Siegel's "Molecule 520" Stock Legit? 7

Molecule 520 Review

RECOMMENDED: Go here to see my no.1 recommendation for making money online

Introduction to Molecule 520

Molecule 520 is the name Jeff Siegel gives to a compound that can be used to formulate therapies that can tackle a wide range of ailments. 

Throughout the presentation, he presents it as capable of curing conditions like PTSD, diabetes, depression, anorexia, Alzheimer’s disease, and addictions to alcohol and opioids in an effective way devoid of complications and side effects.

Molecule 520

Even the FDA has given it the “breakthrough status.

Jeff points out that a growing number of companies are currently conducting clinical trials on Molecule 520 medications; big pharmaceutical companies and tiny startups are spending a lot of money on research.

This has eventually led to venture capitalists and Silicon Valley titans pouring loads of money hoping that molecule 520 will have the impact on their finances similar to that of medical marijuana.

Seeing all that, Jeff claims that it is an opportunity to make triple- or even quadruple-digit profits if you back the right biotech companies.

He has already identified his ideal pick: a little-known Molecule 520 company that is on the verge of going public and may possibly achieve unicorn status (a startup worth $1 billion) when everything goes according to plan. 

RECOMMENDED: Go here to see my no.1 recommendation for making money online

Who Is Behind Molecule 520?

Jeff Siegel is the guru behind this presentation. He has been a professional investor for three decades whom in addition to trading professionally, has been writing about the markets and revealing niche opportunities to his readers. He is on the editorial team of Angel PublishingJeff Siegel edits Topline Trader and Green Chip Stocks.

(Do not confuse him with Jeff Brown or Jeff Clark, both of whom I’ve covered extensively on this blog).

Jeff’s area of expertise is finding world-changing breakthroughs and investing accordingly before Wall Street investors catch wind of them and create massive demand. This gives him and his readers the opportunity to make money before most investors even know what’s happening.

In addition to that, he has established himself as a bestselling author as well as a television commentator.

RECOMMENDED: Go here to see my no.1 recommendation for making money online

How Does Molecule 520 Work?

What Jeff Siegel refers to as Molecule 520 is actually a psychedelic (although he doesn’t specify which one). 

Psychedelics are plant-based compounds that, when consumed, give you a state of consciousness whose proponents claim enables you to alleviate cravings (for example, addictions to alcohol and opioids). Jeff says that it also cures a bunch of ailments without harmful side effects.

Psychedelics are still classified as Schedule 1, which means they are illegal at the federal level. But much like cannabis, this doesn’t stop researchers from looking into them as potential therapies.

This is the narrative that Jeff Siegel pushes in his presentation.

How to invest in Molecule 520

Jeff Siegel has been writing about psychedelics (as investment-worthy) for a few months now. He is even willing to send you a free report on how they work. It is called The Magic Molecule: The Most Important Discovery in Half a Century. 

Through his articles, he has even namedropped a few private companies involved with psychedelic-related cures. A few examples of those companies include Clear Sky Addiction Solutions, Numinus Wellness (CVE: NUMI), and ATAI Life Sciences.

In the presentation, he talks of three companies that he wants you to invest in. He has written a dossier with the heading Three Magic Molecule Picks for Quadruple-Digit Gains discussing them and sharing details about them.

I deduced the name of one of the companies in that report from the clues he dropped in the pitch. It is a company called Mind Medicine Inc. or MindMed (OTCBB: MMEDF) (MMED.NE).

I couldn’t determine the other two and I suppose you have to read the report to reveal their names.

To receive a copy, you have to sign up for Jeff Siegel’s newsletter, Green Chip Stocks.

When you subscribe to Green Chip Stocks, in addition to the two newsletters, you will receive:

  • Weekly updates
  • Unlimited 24/7 access to the members-only website
  • Invitations to private research trips
  • Customer support

How much does it cost to join Green Chip Stocks

A one-year subscription costs $99. Alternatively, you can opt for the two-year subscription for $179.

The Refund Policy

You can request for a full refund if you cancel your membership within 6 months of joining.

RECOMMENDED: Go here to see my no.1 recommendation for making money online

Is Molecule 520 Legit?

Jeff Siegel’s Molecule 520 presentation is legit.

As we have established “Molecule 520” is a term he coined to refer to psychedelics. Although they are considered Schedule 1, research can still be done to determine their viability as potential therapies; and that’s what institutions like Harvard, John Hopkins, and Stanford are undertaking.

Big-name investors, seeing the opportunity to make money, have also started pouring money into biotechs working on psychedelic-based treatments. A verifiable example Jeff gives is Kevin O’Leary (from Shark Tank) who even tweeted in December (2019) about investing in psychedelics.

That said, there are no guarantees that investing in the companies Jeff proposes will earn you big returns. Take his recommendations with a grain of salt.

Molecule 520 Verdict

When Jeff Siegel published his Molecule 520 presentation, he was mostly interested in promoting his newsletter, Green Chip Stocks. However, along the way, he helped educate us (if you had no idea this existed) that psychedelics could seriously make for a viable cure for things like opioid addiction, depression, PTSD, and alcoholism.

Siegel proposes that if you invest early in companies developing those therapies, you could have the opportunity to make up to 70,000% returns on your investments. 

Based on how marijuana has been adopted as a therapy, Jeff probably sees psychedelics following the same trajectory. If he is right, this could be a nice way to invest but if he is proven wrong, you could lose money. Either way, this is uncharted territory and we’ll just have to wait and see whether he will be vindicated.

If you plan on buying his newsletter and investing in his recommendations, do more research before you commit. Also, do not invest more than you are willing to lose.

Before you leave

If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.

It’s helped me earn over $300,000 in the last 12 months alone:

Go here to see my no.1 recommendation for making money online

(This is a 100% free training)

Is Jeff Siegel's "Molecule 520" Stock Legit? 7